Abstract
A 69-year-old woman was admitted to our hospital with the complaint of a right breast mass. As a result of thorough examinations, she was diagnosed with breast cancer and underwent breast-conserving surgery. The pathological findings of the resected specimen showed that the tumor consisted of intermingled carcinomatous and sarcomatous components with a transition zone. On immunohistochemical study, the sarcomatous cells in this transition zone showed partial positive staining for CD10, the myoepithelial marker, suggesting that the myoepithelial cells had transformed into sarcoma, and then this biphasic tumor was formed. Finally, she was diagnosed with biphasic metaplastic sarcomatoid carcinoma of the breast. Biphasic metaplastic sarcomatoid carcinoma of the breast is a relatively rare but aggressive disease. The pathological diagnosis is often controversial, requiring detailed immunohistochemical analysis. We report our experience with a case of biphasic metaplastic sarcomatoid carcinoma of the breast.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gutman H, Pollock RE, Janjan NA, Johnston DA. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg. 1995;180:193–9.
Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasm of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol. 1993;10:128–36.
Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol. 2006;17:605–13.
Foschini MP, Eusebi V. Carcinomas of the breast showing myoepithelial cell differentiation: a review of the literature. Virchows Arch. 1998;432:303–10.
Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi T, Hattori T. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol. 2002;15:397–405.
Tokudome N, Sakamoto G, Sakai T, Sarumaru S, Okuyama N, Hori F, et al. A case of carcinosarcoma of the breast. Breast Cancer. 2005;12:149–53.
Harris M, Persaud V. Carcinosarcoma of the breast. J Pathol. 1974;112:99–105.
Teixeira MR, Qvist H, Bohler PJ, Pandis N, Heim S. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes Chromosomes Cancer. 1998;22:145–51.
Brenner RJ, Turner RR, Schiller V, Arndt RD, Giuliano A. Metaplastic carcinoma of the breast: report of three cases. Cancer. 1998;82:1082–7.
Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. 3. Carcinosarcoma. Cancer. 1989;64:1490–9.
Leibl S, Moinfar F. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation. Am J Surg Pathol. 2006;30:450–6.
Kurian KM, Al-Nafussi A. Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases. Histopathology. 2002;40:58–64.
Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: Prognosis and response to systemic therapy. Ann Oncol. 1999;10:413–9.
Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for HER-2 but frequent express EGFR (HER-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol. 2005;58:700–4.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Haruki, T., Maeta, H., Sawazumi, Y. et al. Biphasic metaplastic sarcomatoid carcinoma of the breast: report of a case. Breast Cancer 16, 229–233 (2009). https://doi.org/10.1007/s12282-008-0091-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-008-0091-7